Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |
08/13/2009 | WO2009100447A2 Detection of degradative enzymes and biomolecules in bodily fluids |
08/13/2009 | WO2009100442A2 Methods for detecting molecule-molecule interactions with a single detection channel |
08/13/2009 | WO2009100410A2 Method and system for analysis of flow cytometry data using support vector machines |
08/13/2009 | WO2009100390A2 Classifying amyloidosis |
08/13/2009 | WO2009100370A1 Methods of treating migraine based on rhythmic sodium levels |
08/13/2009 | WO2009100327A2 Methods of diagnosing chronic prostatitis/chronic pelvic pain syndrome |
08/13/2009 | WO2009100262A2 Oral care methods and systems |
08/13/2009 | WO2009100243A2 Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients |
08/13/2009 | WO2009100229A1 Methods for analysis of vitamins |
08/13/2009 | WO2009100201A2 Functionalized platform for arrays configured for optical detection of targets and related arrays, methods and systems |
08/13/2009 | WO2009100155A1 Compounds and methods for rapid labeling of n-glycans |
08/13/2009 | WO2009100131A2 Process to diagnose or treat brain injury |
08/13/2009 | WO2009100033A1 Improved peptide identification and quantitation by merging ms/ms spectra |
08/13/2009 | WO2009099896A1 Thermal denaturation screening assay to identify candidate compounds for prevention and treatment of parkinson's disease |
08/13/2009 | WO2009099741A1 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods |
08/13/2009 | WO2009099687A1 Methods for analyzing and removing contaminants in liquid hydrocarbon media |
08/13/2009 | WO2009099685A2 High pressure enzymatic digestion system for protein characterization |
08/13/2009 | WO2009099601A2 Chk1 suppresses a caspase-2 apoptotic response to dna damage that bypasses p53, bcl-2 and caspase-3 |
08/13/2009 | WO2009099561A2 Urinary ca125 peptides as biomarkers of ovarian cancer |
08/13/2009 | WO2009099512A2 Centrifugal fluid analyzer rotor |
08/13/2009 | WO2009099394A1 Binding protein and epitope-blocking elisa for the universal detection of h5-subtype influenza viruses |
08/13/2009 | WO2009099391A1 Method and device for studying transport of an agent across a bilayer membrane in bioanalytical sensor applications |
08/13/2009 | WO2009099379A1 Method, computer program product and system for enabling clinical decision support |
08/13/2009 | WO2009099269A1 System for the quantitative measurement of glycohemoglobin and a method for measuring the content of glycohemoglobin using the same |
08/13/2009 | WO2009099240A1 Reagent composition for the treamtment of specimens for immunoassays |
08/13/2009 | WO2009099228A1 Method for prediction and test of heart failure, and reagent and kit for use in the test |
08/13/2009 | WO2009099204A1 Method and kit for detection of anti-avibacterium paragallinarum antibody |
08/13/2009 | WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof |
08/13/2009 | WO2009099149A1 Anti-d-amino acid monoclonal antibody, and immunological analysis method for d-amino acid using anti-d-amino acid monoclonal antibody |
08/13/2009 | WO2009099147A1 Il-1 type ii receptor gene-deficient mutant of mouse |
08/13/2009 | WO2009099073A1 Modified trna containing non-natural nucleotide and use thereof |
08/13/2009 | WO2009099014A1 Fluid identifying method and fluid identifying apparatus |
08/13/2009 | WO2009099005A1 Method of evaluating gastric cancer, gastric cancer evaluation apparatus, gastric cancer evaluation method, gastric cancer evaluation system, gastric cancer evaluation program and recording medium |
08/13/2009 | WO2009098885A1 Dectin-2 gene-deficient non-human animal |
08/13/2009 | WO2009098701A1 Siva 2 stabilization |
08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
08/13/2009 | WO2009098689A1 Immuno-detection of a cancerous state in a subject |
08/13/2009 | WO2009098656A2 Method for predicting or diagnosing outcome of intracranial tumors in a subject |
08/13/2009 | WO2009098623A1 Magnetic bead actuation using feedback for ftir biosensor |
08/13/2009 | WO2009098510A2 Nanoparticle conjugates |
08/13/2009 | WO2009098492A2 Modulation of adenoviral tropism |
08/13/2009 | WO2009098451A2 Biomarkers of aminopeptidase inhibition |
08/13/2009 | WO2009098450A2 Methods and compositions |
08/13/2009 | WO2009098396A1 Blood markers of transplanted intestine rejection |
08/13/2009 | WO2009098354A1 Method of diagnosing irritable bowel syndrome ibs |
08/13/2009 | WO2009098344A1 Compositions and methods for modulating p300 activity |
08/13/2009 | WO2009098313A1 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate |
08/13/2009 | WO2009098290A1 Fto-modified non-human mammal |
08/13/2009 | WO2009098272A2 Microfluidic device for assessing object / test material interactions |
08/13/2009 | WO2009098237A1 A milk analysis microfluidic apparatus for detecting mastitis in a milk sample |
08/13/2009 | WO2009098197A1 Target sequences and methods to identify the same, useful in treatment of neurodegenerative diseases |
08/13/2009 | WO2009098196A2 Molecular targets and compounds, methods to identify the same, useful in the treatment of neurodegenerative diseases. |
08/13/2009 | WO2009098192A1 Mr imaging agent or medium compressing hzperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
08/13/2009 | WO2009098191A2 Method to produce hyperpolarised amino acids and aminosulphonic acids |
08/13/2009 | WO2009098123A1 Molecule chip devices and uses thereof |
08/13/2009 | WO2009098021A1 Selectivity profiling of pi3k interacting molecules against multiple targets |
08/13/2009 | WO2009097692A1 Biomarkers for head-and-neck cancers and precancers |
08/13/2009 | WO2009081291A3 Field effect transistors for detection of nosocomial infection |
08/13/2009 | WO2009077864A3 Compositions and methods of detecting tiabs |
08/13/2009 | WO2009076287A3 System and method of assessing a property of a flowing fluid |
08/13/2009 | WO2009075891A3 Magnetoelastic sensor element having a liquid-solid interface with a roughened nano/microstructure |
08/13/2009 | WO2009075863A3 Method for diagnosing stroke |
08/13/2009 | WO2009075799A3 Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells |
08/13/2009 | WO2009074326A3 Use of kir genes for predicting response to therapy |
08/13/2009 | WO2009073540A3 Vegf polymorphisms and anti-angiogenesis therapy |
08/13/2009 | WO2009072009A3 Method for determining the toxicity of a toxin or a toxoid |
08/13/2009 | WO2009067501A3 Infrared thermography for monitoring brown adipose tissue |
08/13/2009 | WO2009063208A3 Protease detection |
08/13/2009 | WO2009060317A3 Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy |
08/13/2009 | WO2009055616A3 Genetic incorporation of 3-aminotyrosine into reductases |
08/13/2009 | WO2009052972A3 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
08/13/2009 | WO2009051842A3 Detection of cancer by measuring genomic copy number and strand length in cell-free dna |
08/13/2009 | WO2009047513A3 Antagonists of kisspeptin and uses thereof |
08/13/2009 | WO2009046251A3 Specificity and sensitivity enhancement in piezoelectric cantilever sensing |
08/13/2009 | WO2009032316A9 Genetic polymorphisms associated with rheumatoid arhritis, methods of detection and uses thereof |
08/13/2009 | WO2009030908A3 Thermal control apparatus for chemical and biochemical reactions |
08/13/2009 | WO2009014787A3 Multianalyte assay |
08/13/2009 | WO2009007676A3 Biomolecule binding ligands |
08/13/2009 | WO2008140475A3 Imaging contrast agents using nanoparticles |
08/13/2009 | WO2008107691A9 Methods and apparatus for particle detection |
08/13/2009 | WO2008057613A9 A magnetic resonance system and method to detect and confirm analytes |
08/13/2009 | WO2007119165A8 A method for detecting intracytoplasmic protein/protein interactions |
08/13/2009 | WO2007113685A8 USE OF THE α CHAIN OF BRAIN SPECTRIN AND FRAGMENTS THEREOF, FOR DIAGNOSING CEREBRAL DISEASES |
08/13/2009 | WO2003003984A8 Novel proteins and nucleic acids encoding same |
08/13/2009 | US20090205061 Taste Receptors Of The T1R Family From Domestic Cat |
08/13/2009 | US20090205056 Method of screening for modulators of map3k11 in liver cancer cells |
08/13/2009 | US20090204379 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
08/13/2009 | US20090204366 Apparatus and method for non-invasive measurement of the concentration of a substance in subject's blood |
08/13/2009 | US20090204342 Methods and apparatus for wafer area pressure control in an adjustable gap plasma chamber |
08/13/2009 | US20090204341 Signal processing for continuous analyte sensor |
08/13/2009 | US20090204340 Method Of Calibrating An Analyte-Measurement Device, And Associated Methods, Devices And Systems |
08/13/2009 | US20090204339 Apparatus, method and computer program product for determining confidence measures and combined confidence measures for assessing the quality of proteomic and genomic data |
08/13/2009 | US20090204338 Method of deriving a quantitative measure of the instability of calcific deposits of a blood vessel |
08/13/2009 | US20090204337 Method for Identifying the Elution Time of an Analyte |
08/13/2009 | US20090204334 Lung cancer biomarkers |
08/13/2009 | US20090204333 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
08/13/2009 | US20090203982 Glucose Measuring Device For Use In Personal Area Network |
08/13/2009 | US20090203895 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |